Le programme de l’équipe neurovasculaire dont le Dr Steve Verreault fait partie se spécialise dans :
le traitement de l’AVC aigu ischémique et hémorragique
la prévention secondaire des AVC/ICT et
des sténoses carotidiennes symptomatiques et asymptomatiques
63859
Québec, Québec
Canada G1J 1Z4
- Falardeau, NadineEmployé+1 418-525-4444, poste 65892nadine.falardeau@crchudequebec.ulaval.ca
- Lavoie, SuzyEmployéHôpital de l'Enfant-Jésus+1 418-649-0252, poste 65543+1 418-649-5542+1 418-649-5733Suzy.Lavoie@crchudequebec.ulaval.ca
1401, 18e Rue
Z-252
Québec, Québec
Canada G1J 1Z4
Intra-arterial milrinone for reversible cerebral vasoconstriction syndrome
Article de revueHeadache, 49 (1), 2009.
Atherosclerotic burden findings in young cryptogenic stroke patients with and without a patent foramen ovale
Article de revueStroke, 40 (2), 2009.
Intravascular lymphoma with conus medullaris syndrome followed by encephalopathy
Article de revueCan J Neurol Sci, 35 (3), 2008.
Mutations in SYNE1 lead to a newly discovered form of autosomal recessive cerebellar ataxia
Article de revueNat Genet, 39 (1), 2007.
Clinical and genetic study of autosomal recessive cerebellar ataxia type 1
Article de revueAnn Neurol, 62 (1), 2007.
A case of familial Creutzfeldt-Jakob disease presenting with dry cough
Article de revueCan J Neurol Sci, 33 (2), 2006.
A novel hereditary small vessel disease of the brain
Article de revueAnn Neurol, 59 (2), 2006.
High efficiency of muscle regeneration after human myoblast clone transplantation in SCID mice
Article de revueJ Clin Invest, 93 (2), 1994.
Human myoblast transplantation in immunodeficient and immunosuppressed mice: evidence of rejection
Article de revueMuscle Nerve, 17 (2), 1994.
Utilization of an antibody specific for human dystrophin to follow myoblast transplantation in nude mice
Article de revueCell Transplant, 2 (2), 1993.
Projets actifs
- StATins Use in intRacerebral hemorrhage patieNts (SATURN), du 2023-09-06 au 2028-12-25